Information about Xopenex from Sepracor.

March 26, 1999: The United States Food and Drug Administration has approved Sepracor Inc.'s Xopenex (levalbuterol HCl) inhalation solution in two dosage strengths for use with a nebulizer for the treatment and prevention of bronchospasm.